Total Payments
$21,294
2023 Payments
$127.42
Companies
17
Transactions
273
Medicare Patients
15,555
Medicare Billing
$1.3M
Payment Breakdown by Category
Other$15,500 (72.8%)
Food & Beverage$5,299 (24.9%)
Consulting$275.00 (1.3%)
Education$219.78 (1.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $15,500 | 13 | 72.8% |
| Food and Beverage | $5,299 | 255 | 24.9% |
| Consulting Fee | $275.00 | 1 | 1.3% |
| Education | $219.78 | 4 | 1.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AbbVie Inc. | $17,429 | 80 | $0 (2023) |
| Lilly USA, LLC | $1,146 | 92 | $0 (2020) |
| Galderma Laboratories, L.P. | $590.74 | 11 | $0 (2019) |
| Janssen Biotech, Inc. | $584.96 | 27 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $474.44 | 30 | $0 (2020) |
| UCB, Inc. | $310.81 | 20 | $0 (2019) |
| Promius Pharma LLC | $275.00 | 1 | $0 (2017) |
| DUSA Pharmaceuticals, Inc. | $168.91 | 1 | $0 (2017) |
| Janssen Scientific Affairs, LLC | $128.83 | 1 | $0 (2017) |
| Sun Pharmaceutical Industries Inc. | $38.77 | 2 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $127.42 | 2 | AbbVie Inc. ($112.08) |
| 2022 | $309.80 | 14 | ABBVIE INC. ($281.21) |
| 2021 | $2,413 | 4 | AbbVie Inc. ($2,413) |
| 2020 | $7,838 | 26 | AbbVie Inc. ($7,593) |
| 2019 | $7,039 | 88 | AbbVie, Inc. ($6,178) |
| 2018 | $1,807 | 94 | AbbVie, Inc. ($814.76) |
| 2017 | $1,759 | 45 | Galderma Laboratories, L.P. ($553.40) |
All Payment Transactions
273 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 01/30/2023 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $15.34 | General |
| Category: DERMATOLOGY | ||||||
| 01/12/2023 | AbbVie Inc. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $112.08 | General |
| Category: IMMUNOLOGY | ||||||
| 12/21/2022 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $25.56 | General |
| Category: IMMUNOLOGY | ||||||
| 12/01/2022 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $14.67 | General |
| Category: Immunology | ||||||
| 11/18/2022 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI, RINVOQ | Food and Beverage | In-kind items and services | $120.42 | General |
| Category: IMMUNOLOGY | ||||||
| 10/24/2022 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $4.86 | General |
| Category: IMMUNOLOGY | ||||||
| 10/08/2022 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $20.73 | General |
| Category: IMMUNOLOGY | ||||||
| 07/14/2022 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $5.59 | General |
| Category: IMMUNOLOGY | ||||||
| 06/27/2022 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $5.69 | General |
| Category: IMMUNOLOGY | ||||||
| 06/06/2022 | PFIZER INC. | CIBINQO (Drug) | Food and Beverage | In-kind items and services | $13.92 | General |
| Category: Inflammation & Immunology | ||||||
| 06/01/2022 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $18.82 | General |
| Category: IMMUNOLOGY | ||||||
| 04/26/2022 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $20.07 | General |
| Category: IMMUNOLOGY | ||||||
| 04/19/2022 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $5.63 | General |
| Category: IMMUNOLOGY | ||||||
| 02/24/2022 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $7.92 | General |
| Category: IMMUNOLOGY | ||||||
| 02/14/2022 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $25.96 | General |
| Category: IMMUNOLOGY | ||||||
| 01/29/2022 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $19.96 | General |
| Category: IMMUNOLOGY | ||||||
| 12/21/2021 | AbbVie Inc. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $5.58 | General |
| Category: IMMUNOLOGY | ||||||
| 10/13/2021 | AbbVie Inc. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $6.97 | General |
| Category: IMMUNOLOGY | ||||||
| 01/19/2021 | AbbVie Inc. | HUMIRA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,200.00 | General |
| Category: IMMUNOLOGY | ||||||
| 01/18/2021 | AbbVie Inc. | HUMIRA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,200.00 | General |
| Category: IMMUNOLOGY | ||||||
| 12/15/2020 | AbbVie Inc. | SKYRIZI (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,200.00 | General |
| Category: IMMUNOLOGY | ||||||
| 12/08/2020 | Novartis Pharmaceuticals Corporation | COSENTYX (Biological) | Food and Beverage | In-kind items and services | $11.67 | General |
| Category: IMMUNOLOGY | ||||||
| 12/07/2020 | AbbVie Inc. | SKYRIZI (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,200.00 | General |
| Category: IMMUNOLOGY | ||||||
| 11/24/2020 | AbbVie Inc. | SKYRIZI (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,200.00 | General |
| Category: IMMUNOLOGY | ||||||
| 11/16/2020 | AbbVie Inc. | SKYRIZI (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,200.00 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 26 | 5,349 | 9,017 | $2.2M | $480,107 |
| 2022 | 22 | 3,472 | 7,713 | $690,775 | $271,723 |
| 2021 | 29 | 3,471 | 8,088 | $744,775 | $294,944 |
| 2020 | 24 | 3,263 | 7,495 | $713,082 | $258,228 |
Total Patients
15,555
Total Services
32,313
Medicare Billing
$1.3M
Procedure Codes
101
All Medicare Procedures & Services
101 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 967 | 967 | $496,036 | $131,529 | 26.5% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 520 | 603 | $232,930 | $54,445 | 23.4% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 627 | 728 | $228,716 | $48,041 | 21.0% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 926 | 1,169 | $381,095 | $42,688 | 11.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 345 | 432 | $172,294 | $40,273 | 23.4% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 243 | 272 | $169,840 | $36,943 | 21.8% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 248 | 478 | $33,254 | $20,553 | 61.8% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 619 | 3,431 | $32,999 | $18,671 | 56.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 234 | 263 | $83,021 | $15,303 | 18.4% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 50 | 52 | $47,158 | $12,676 | 26.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 141 | 141 | $54,319 | $12,603 | 23.2% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 69 | 86 | $43,995 | $11,145 | 25.3% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 43 | 43 | $14,500 | $4,585 | 31.6% |
| 10061 | Complicated or multiple drainage of skin abscess | Office | 2023 | 20 | 21 | $17,598 | $3,807 | 21.6% |
| 17272 | Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm | Office | 2023 | 22 | 26 | $14,948 | $3,551 | 23.8% |
| 11302 | Shaving of skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 28 | 30 | $11,340 | $3,385 | 29.8% |
| 69100 | Biopsy of ear | Office | 2023 | 57 | 60 | $38,094 | $3,194 | 8.4% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 28 | 29 | $23,369 | $3,010 | 12.9% |
| 12031 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.5 cm or less | Office | 2023 | 12 | 13 | $9,997 | $2,966 | 29.7% |
| 11105 | Punch biopsy, each additional skin growth | Office | 2023 | 34 | 45 | $3,240 | $2,306 | 71.2% |
| 10060 | Simple or single drainage of skin abscess | Office | 2023 | 21 | 21 | $9,587 | $2,101 | 21.9% |
| 11301 | Shaving of skin growth of body, arms, or legs, 0.6-1.0 cm | Office | 2023 | 18 | 23 | $8,122 | $1,851 | 22.8% |
| 11402 | Removal of noncancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 22 | 23 | $19,722 | $1,773 | 9.0% |
| 11307 | Shaving of skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm | Office | 2023 | 14 | 14 | $5,222 | $1,567 | 30.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 30 | 30 | $7,202 | $1,127 | 15.6% |
About Dr. Jamie Devito, MD
Dr. Jamie Devito, MD is a Dermatology healthcare provider based in Palm Springs, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/11/2006. The National Provider Identifier (NPI) number assigned to this provider is 1326072455.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jamie Devito, MD has received a total of $21,294 in payments from pharmaceutical and medical device companies, with $127.42 received in 2023. These payments were reported across 273 transactions from 17 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($15,500).
As a Medicare-enrolled provider, Devito has provided services to 15,555 Medicare beneficiaries, totaling 32,313 services with total Medicare billing of $1.3M. Data is available for 4 years (2020–2023), covering 101 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Location Palm Springs, CA
- Active Since 07/11/2006
- Last Updated 03/06/2025
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1326072455
Products in Payments
- SKYRIZI (Biological) $7,656
- Skyrizi (Biological) $5,914
- HUMIRA (Biological) $2,400
- Humira (Biological) $1,085
- TALTZ (Drug) $933.92
- COSENTYX (Biological) $474.44
- STELARA (Biological) $446.67
- RINVOQ (Biological) $343.33
- Cimzia (Drug) $310.81
- Cloderm Cream (Drug) $275.00
- Levulan (Drug) $168.91
- Tremfya (Drug) $164.32
- EPIDUO FORTE (Drug) $141.01
- REMICADE (Biological) $102.80
- DUPIXENT DUPILUMAB INJECTION (Biological) $35.49
- Enbrel (Biological) $23.39
- DUPIXENT (Drug) $22.68
- ILUMYA (tildrakizumab-asmn) injection (Biological) $21.16
- ONEXTON (Drug) $21.15
- ILUMYA (Biological) $17.61
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.